Thalamic Involvement and Its Impact on Clinical Disability in Patients with Multiple Sclerosis: A Diffusion Tensor Imaging Study at 3T

References

1. ↵
   Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 1999;5:283–86

   Abstract/FREE Full Text
2. ↵
   McFarland HF, Barkhof F, Antel J, et al. The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler 2002;8:40–51

   Abstract/FREE Full Text
3. ↵
   Filippi M. Non-conventional MR techniques to monitor the evolution of multiple sclerosis. Neurol Sci 2001;22:195–200

   CrossRefPubMed
4. ↵
   Bagnato F, Frank JA. The role of nonconventional magnetic resonance imaging techniques in demyelinating disorders. Curr Neurol Neurosci Rep 2003;3:238–45

   CrossRefPubMed
5. ↵
   Cifelli A, Arridge M, Jezzard P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650–53

   CrossRefPubMedWeb of Science
6. ↵
   Kutzelnigg A, Lassmann H. Cortical lesions and brain atrophy in MS. J Neurol Sci 2005;233:55–59

   CrossRefPubMedWeb of Science
7. ↵
   Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357–81

   CrossRefPubMedWeb of Science
8. ↵
   Richert ND, Ostuni JL, Bash CN, et al. Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b. AJNR Am J Neuroradiol 1998;19:1705–13

   Abstract
9. ↵
   Griffin CM, Chard DT, Ciccarelli O, et al. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Mult Scler 2001;7:290–97

   Abstract/FREE Full Text
10. ↵
    Filippi M, Bozzali M, Comi G. Magnetization transfer and diffusion tensor MR imaging of basal ganglia from patients with multiple sclerosis. J Neurol Sci 2001;183:69–72

    CrossRefPubMedWeb of Science
11. ↵
    Fabiano AJ, Sharma J, Weinstock-Guttman B, et al. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. J Neuroimaging 2003;13:307–14

    CrossRefPubMedWeb of Science
12. Bermel RA, Innus MD, Tjoa CW, et al. Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study. Neuroreport 2003;14:335–39

    CrossRefPubMedWeb of Science
13. Inglese M, Ge Y, Filippi M, et al. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage 2004;21:1825–29

    CrossRefPubMedWeb of Science
14. ↵
    Audoin B, Ranjeva JP, Au Duong MV, et al. Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis. J Magn Reson Imaging 2004;20:765–71

    CrossRefPubMedWeb of Science
15. ↵
    Cao M, Calabrese M, Gupta S, et al. Deep grey matter disease in multiple sclerosis: a primary or secondary pathogenetic process. Mult Scler 2005;11:232

    Abstract/FREE Full Text
16. ↵
    Geurts JJ, Reuling IE, Vrenken H, et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 2006;55:478–83

    CrossRefPubMedWeb of Science
17. ↵
    Sharma J, Zivadinov R, Jaisani Z, et al. A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis. J Neuroimaging 2006;16:302–10

    PubMed
18. ↵
    Davies GR, Altmann DR, Hadjiprocopis A, et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005;252:1037–44

    CrossRefPubMedWeb of Science
19. ↵
    Derache N, Marie RM, Constans JM, et al. Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load. J Neurol Sci 2006;245:103–09

    CrossRefPubMedWeb of Science
20. ↵
    Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111:209–19

    CrossRefPubMedWeb of Science
21. ↵
    Hagmann P, Thiran JP, Jonasson L, et al. DTI mapping of human brain connectivity: statistical fibre tracking and virtual dissection. Neuroimage 2003;19:545–54

    CrossRefPubMedWeb of Science
22. ↵
    O'Sullivan M, Singhal S, Charlton R, et al. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology 2004;62:702–07

    Abstract/FREE Full Text
23. ↵
    Hagmann P, Jonasson L, Maeder P, et al. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics 2006;26 (suppl 1):S205–23

    CrossRefPubMedWeb of Science
24. ↵
    Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926–33

    Abstract/FREE Full Text
25. ↵
    Ceccarelli A, Rocca MA, Falini A, et al. Normal-appearing white and grey matter damage in MS: a volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol 2007;254:513–18

    CrossRefPubMedWeb of Science
26. ↵
    Alexander AL, Lee JE, Wu YC, et al. Comparison of diffusion tensor imaging measurements at 3.0 T versus 1.5 T with and without parallel imaging. Neuroimaging Clin N Am 2006;16:299–309, xi

    CrossRefPubMedWeb of Science
27. ↵
    Fushimi Y, Miki Y, Okada T, et al. Fractional anisotropy and mean diffusivity: comparison between 3.0-T and 1.5-T diffusion tensor imaging with parallel imaging using histogram and region of interest analysis. NMR Biomed 2007;20:743–48

    CrossRefPubMed
28. ↵
    Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–31

    CrossRefPubMedWeb of Science
29. ↵
    Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey—National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907–11

    Abstract/FREE Full Text
30. ↵
    Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52

    Abstract/FREE Full Text
31. ↵
    Gronwall D, Wrightson P. Delayed recovery of intellectual function after minor head injury. Lancet 1974;2:605–09

    PubMedWeb of Science
32. ↵
    Gronwall D, Wrightson P. Memory and information processing capacity after closed head injury. J Neurol Neurosurg Psychiatry 1981;44:889–95

    Abstract/FREE Full Text
33. ↵
    Gupta S, Solomon JM, Tasciyan TA, et al. Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis. Mult Scler 2005;11:658–68

    Abstract/FREE Full Text
34. ↵
    Bagnato F, Jeffries N, Richert ND, et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 2003;126:1782–89

    Abstract/FREE Full Text
35. ↵
    Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–89

    CrossRefPubMedWeb of Science
36. ↵
    Jezzard P, Balaban RS. Correction for geometric distortion in echo planar images from B0 field variations. Magn Reson Med 1995;34:65–73

    CrossRefPubMedWeb of Science
37. ↵
    Woods RP, Grafton ST, Holmes CJ, et al. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 1998;22:139–52

    CrossRefPubMedWeb of Science
38. ↵
    Jiang H, van Zijl PC, Kim J, et al. DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 2006;81:106–16

    CrossRefPubMedWeb of Science
39. ↵
    Codella M, Rocca MA, Colombo B, et al. Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study. J Neurol Sci 2002;194:71–74

    CrossRefPubMedWeb of Science
40. Rovaris M, Bozzali M, Iannucci G, et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. Arch Neurol 2002;59:1406–12

    CrossRefPubMedWeb of Science
41. ↵
    Rovaris M, Judica E, Gallo A, et al. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 2006;129:2628–34

    Abstract/FREE Full Text
42. ↵
    Behrens TE, Johansen-Berg H, Woolrich MW, et al. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 2003;6:750–57

    CrossRefPubMedWeb of Science
43. ↵
    Audoin B, Guye M, Reuter F, et al. Structure of WM bundles constituting the working memory system in early multiple sclerosis: a quantitative DTI tractography study. Neuroimage 2007;36:1324–30

    CrossRefPubMedWeb of Science
44. ↵
    Pierpaoli C, Barnett A, Pajevic S, et al. Water diffusion changes in wallerian degeneration and their dependence on white matter architecture. Neuroimage 2001;13:1174–85

    PubMedWeb of Science
45. ↵
    Inglese M, Liu S, Babb JS, et al. Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. Neurology 2004;63:170–72

    Abstract/FREE Full Text
46. ↵
    Kidd D, Barkhof F, McConnell R, et al. Cortical lesions in multiple sclerosis. Brain 1999;122:17–26

    Abstract/FREE Full Text
47. ↵
    Johansen-Berg H, Behrens TE, Sillery E, et al. Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex 2005;15:31–39

    Abstract/FREE Full Text